CAM Guidance Statement On Probiotics Is “Astonishing,” Concerns Experts
This article was originally published in The Tan Sheet
Executive Summary
FDA's Center for Biologics Evaluation and Research may be laying the groundwork for greater control of the regulation of probiotics in the agency's recently released guidance document on "complementary and alternative medicine products," according to industry stakeholders